Medical News

RSS

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestations of chronic Graft-versus-Host disease.

2 Dec 2013

Shire signs agreement to supply authorized generic version of Adderall XR

Shire plc, announces that its subsidiary Shire US Inc. has entered into an agreement to supply an authorized generic version of its product Adderall XR.

2 Dec 2013

First Edition: December 2, 2013

Today's early morning highlights from the major news organizations, including reports about healthcare.gov's status, the challenges that lie ahead and the concerns being expressed by consumers and insurers.

2 Dec 2013

WHO releases new report on spinal cord injury

As many as 500 000 people suffer a spinal cord injury each year. People with spinal cord injuries are 2 to 5 times more likely to die prematurely, with worse survival rates in low- and middle-income countries. The new WHO report, "International perspectives on spinal cord injuries", summarizes the best available evidence on the causes, prevention, care and lived experience of people with spinal cord injury.

2 Dec 2013

Toshiba's M-Power interface simplifies MR scans and helps improve patient care

Healthcare providers are able to do more with less and improve patient care thanks to Toshiba America Medical Systems, Inc.'s enhanced M-Power user interface. Toshiba's M-Power interface simplifies MR scans by automatically guiding clinicians to complete exams accurately and efficiently. Combined with the large bore, quiet MR technology and advanced non-contrast techniques of Toshiba's MR systems, clinicians can offer an overall more comfortable and safer exam.

2 Dec 2013

JHL Biotech installs GE Healthcare's FlexFactory biomanufacturing platform at Hsinchu plant in Taiwan

GE Healthcare Life Sciences and JHL Biotech today announced that GE Healthcare has completed installation of its FlexFactory biomanufacturing platform at JHL Biotech's Research Center and manufacturing plant in Hsinchu, Taiwan.

2 Dec 2013

Healthcare providers can now improve diagnostic confidence with Toshiba's Kalare R&F digital X-ray

Healthcare providers can improve their diagnostic confidence with Toshiba America Medical Systems, Inc.'s more flexible Kalare R&F digital X-ray system. Featuring a new 17" x 17" dynamic flat panel detector (works-in-progress), the system provides clinicians with distortion-free, high-quality images.

2 Dec 2013

Visterra secures exclusive patent license for promising dengue virus antibodies from MIT

Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.

2 Dec 2013

New biomarkers to improve diagnostics of prostate cancer

New biomarkers will improve diagnostics of endemic diseases in future, such as prostate cancer. Their mission: to recognize the tumor earlier and classify it more precisely - thereby helping avoid unnecessary operations.

2 Dec 2013

Parents' unsociable work hours may have negative consequences for children

A comprehensive review of studies on parents' work schedules and child development spanning the last three decades shows that parents' work schedules in evenings, nights and weekends, so called "nonstandard work schedules" or "unsociable work hours", may have negative consequences for children. When parents work such hours, children tended to have more behavioral problems, poorer cognitive ability (e.g., language, reading and mathematics), and were more likely to be overweight or obese than children in families where parents mostly worked during the daytime hours and week day.

2 Dec 2013

Valley Presbyterian Hospital receives First 5 LA grant to implement Welcome Baby program

Valley Presbyterian Hospital was awarded a $772,643 grant from First 5 LA to implement the 'Welcome Baby' prenatal and infant care program. The grant period is from December 1, 2013 through June 30, 2014 and is expected to be extended for an additional year, through June 30, 2015.

2 Dec 2013

Visterra gets $8.1M in proceeds from upsized and final closing of Series A financing round

Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.

2 Dec 2013

New multinational survey to investigate early conversations between physicians and T2D people

Boehringer Ingelheim and Eli Lilly and Company today announced the launch of the largest multinational survey to investigate early conversations between physicians and people living with Type 2 Diabetes. The survey was developed in partnership with the International Diabetes Federation and will include more than 10,000 people with T2D and more than 6,500 treating-physicians across 26 countries worldwide

2 Dec 2013

GFF launches education campaign to stop violence against women in DRC, prevent HIV/AIDS in military

The Gertler Family Foundation, in partnership with the Armed Forces of the Democratic Republic of the Congo, marked World AIDS Day by launching an aggressive new education campaign to stop violence against women in the DRC and prevent the spread of HIV/AIDS in the military.

2 Dec 2013

Nearly 1% of all newborns in Switzerland diagnosed with congenital heart defect

Approximately one percent of all newborns in Switzerland are diagnosed with a congenital heart defect, roughly half of them require open heart surgery. Most children, including those with the most severe heart defects, survive because of the significant advancements in surgical techniques. Therefore, the current research focuses less on survival than on long-term consequences and quality of life of these children.

2 Dec 2013

Northwest ImageShare provides better patient care, shorter wait times in emergency departments

Northwest ImageShare, now installed and running at 42 locations throughout the Kitsap Peninsula, is fulfilling its initial goals of better patient care and shorter wait-times spent in the emergency department.

2 Dec 2013

Pharmaceutical industry in Asia to experience intensified competition

As Asia emerges as a major engine of global economic growth, the pharmaceutical and biotechnology industries in the region are expected to experience intensified competition. According to the Economist Intelligence Unit, regional pharmaceutical sales are expected to hit USD386bn, reflecting an annual average growth rate of more than 13%.

2 Dec 2013

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing, today announces that it is launching a CE/IVD labeled MID kit for Illumina MiSeq together with three new germline mutation detection MASTRTM kits enabling the identification of individuals at risk for maturity onset diabetes of the young, autosomal dominant hypercholesterolemia, and hypertrophic cardiomyopathy.

2 Dec 2013

Cell Therapeutics gets $5 million payment from Teva for TRISENOX

Cell Therapeutics, Inc. today announced that it has received a $5 million milestone payment from Teva Pharmaceutical Industries Ltd. related to the achievement of a sales milestone for TRISENOX (arsenic trioxide).

2 Dec 2013

ResMed completes acquisition of Prague-based Unimedis

Prague-based Unimedis, a distributor of equipment for the treatment of sleep disordered-breathing in the Czech Republic and Slovakia, has been acquired by ResMed, a pioneer and global leader in sleep and respiratory medicine.

From ResMed Corp 2 Dec 2013

Medical News

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Shire signs agreement to supply authorized generic version of Adderall XR

First Edition: December 2, 2013

WHO releases new report on spinal cord injury

Toshiba's M-Power interface simplifies MR scans and helps improve patient care

JHL Biotech installs GE Healthcare's FlexFactory biomanufacturing platform at Hsinchu plant in Taiwan

Healthcare providers can now improve diagnostic confidence with Toshiba's Kalare R&F digital X-ray

Visterra secures exclusive patent license for promising dengue virus antibodies from MIT

New biomarkers to improve diagnostics of prostate cancer

Parents' unsociable work hours may have negative consequences for children

Valley Presbyterian Hospital receives First 5 LA grant to implement Welcome Baby program

Visterra gets $8.1M in proceeds from upsized and final closing of Series A financing round

New multinational survey to investigate early conversations between physicians and T2D people

GFF launches education campaign to stop violence against women in DRC, prevent HIV/AIDS in military

Nearly 1% of all newborns in Switzerland diagnosed with congenital heart defect

Northwest ImageShare provides better patient care, shorter wait times in emergency departments

Pharmaceutical industry in Asia to experience intensified competition

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Cell Therapeutics gets $5 million payment from Teva for TRISENOX

ResMed completes acquisition of Prague-based Unimedis

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News